Holen Sie sich die Stockscreener-App
11.44
0.79%
0.09
Handel nachbörslich:
11.44
Avantor Inc Aktie (AVTR) Neueste Nachrichten
Avantor, Inc. Revenue Breakdown – BMV:AVTR - TradingView
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review
Avantor, Inc. (AVTR) Stock forecasts - Yahoo Finance Singapore
Avantor, Inc. (AVTR) Stock Forecasts - Yahoo Finance
Avantor Inc (AVTR) Stock Up 3.6% and Still Undervalued -- GF Sco - GuruFocus
Avantor stock holds steady as investors weigh recent earnings and life sciences demand - AD HOC NEWS
AVTR: Avantor Inc. Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Avantor, Inc. (AVTR) And Encourages Shareholders to Reach Out - ACCESS Newswire
Avantor, Inc. (AVTR) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Yahoo Finance
Avantor stock trades steady as investors weigh recent earnings and life sciences demand - AD HOC NEWS
Avantor Inc (AVTR) Shares Fall 3.7% -- What GF Score of 61 Tells Investors - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Avantor, Inc. (AVTR) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
2026-07-19 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Avantor, Inc. (AVTR) and Encourages Shareholders to Learn More About the Investigation | NYSE:AVTR | Press Release - Stockhouse
Avantor, Inc. Announces Amendment No. 15 to Credit Agreement, Extending Euro Term Loan Maturity to 2032 - Minichart
Avantor, Inc. (AVTR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Avantor Lowers Borrowing Costs by Refinancing €374.2 Million Euro-Denominated Term Loans with Credit Agreement Amendment - Kalkine Media
Avantor Unit Enters Amendment No. 15 To Credit Agreement On July 14, 2026SEC Filing - TradingView
Avantor Refinances €374.2 Million Euro Term Loans at EURIBO + 2.00% Under Credit Amendment - TradingView
Avantor (NYSE: AVTR) refinances €374,208,296.62 in Euro term loans - Stock Titan
Trading Systems Reacting to (AVTR) Volatility - Stock Traders Daily
Will Avantor (AVTR) beat estimates again in its next earnings report? - MSN
Is Avantor (AVTR) Quietly Redefining Its Healthcare Role With NuSil’s HIV-Prevention Partnership? - simplywall.st
Will Avantor (AVTR) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
Avantor Stock Up on NuSil's Expanded HIV Prevention Partnership - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Encourages Avantor, Inc. (AVTR) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Avantor Jumps 6.2% Amid Sector-Wide Rally - AlphaStreet
Avantor Inc (AVTR) Stock Up 6.9% and Still Undervalued -- GF Sco - GuruFocus
Avantor expands partnership for HIV prevention ring development By Investing.com - Investing.com Nigeria
Avantor expands partnership for HIV prevention ring development - Investing.com
Avantor expands collaboration to develop a thre... - Pluang
New HIV prevention ring could cut use from 12 rings to four - Stock Titan
Price to earnings forward of Avantor, Inc. – LSX:A2PJN6 - TradingView
Avantor, Inc. Stock 12‑Month Price Target Raised to $10.31, Implies 1% Downside - TradingView
BofA Securities Adjusts Avantor Price Target to $12 From $10 - Moomoo
Avantor, Inc. (AVTR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Avantor (AVTR) Gains Traction Under New Management - Yahoo Finance
Avantor, Inc. Stock 12‑Month Price Target Raised to $10.19, Implies 2% Downside - TradingView
Enterprise value to EBITDA forward of Avantor, Inc. – LSX:A2PJN6 - TradingView
Investors in Avantor, Inc. (AVTR): Protect Your Rights – Contact Levi & Korsinsky Before December 29, 2025 - The National Law Review
Avantor stock reflects steady life sciences demand amid global biosciences expansion - ad-hoc-news.de
Bronstein, Gewirtz & Grossman, LLC Is Investigating Avantor, Inc. (AVTR) And Encourages Investors to Connect - ACCESS Newswire
Here's why you should hold Avantor stock in your portfolio for now - MSN
Avantor Inc (AVTR) Stock Up 7.7% and Still Undervalued -- GF Sco - GuruFocus
Avantor stock reflects life science demand amid diversified growth - ad-hoc-news.de
Here's Why You Should Hold Avantor Stock in Your Portfolio for Now - TradingView
Avantor Price Target Raised to $11.00/Share From $9.00 by Citigroup - Moomoo
Avantor Is Maintained at Neutral by Citigroup - Moomoo
Bronstein, Gewirtz & Grossman, LLC Encourages Avantor, Inc. (AVTR) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Avantor Inc focuses on life sciences growth while investors monitor its Nasdaq listing - ad-hoc-news.de
Evercore Maintains Avantor(AVTR.US) With Hold Rating, Raises Target Price to $10.5 - Moomoo
Avantor Is Maintained at In-Line by Evercore ISI Group - Moomoo
Avantor, Inc. (AVTR) Stock Analysis: Navigating a Healthcare Giant with a $7.05 Billion Market Cap - DirectorsTalk Interviews
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Avantor, Inc. (AVTR) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
AVTR Q1 2026 Earnings: EPS Surges Past Estimates, Stock Gains 3.1%Dividend Cut Risk - dars.gov.et
Is Avantor (AVTR) Stock Cheap After A 71% Five Year Fall? - Yahoo Finance
Does Hedge Fund Accumulation Ahead of Earnings Call Reframe Avantor’s (AVTR) Institutional Confidence Story? - Yahoo Finance
Avantor Inc stock highlights life sciences exposure as investors weigh long term demand - Ad-hoc-news.de
AVTR Shareholders Have Opportunity to Lead Avantor, Inc. Class Ac - The National Law Review
Levi & Korsinsky Notifies Avantor, Inc. (AVTR) InvestorsLead Plaintiff Deadline on December 29, 2025 - The National Law Review
Avantor® to Report Second Quarter 2026 Earnings on Wednesday, Ju - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Encourages Avantor, Inc. (AVTR) Investors to Inquire about Securities Investigation - ACCESS Newswire
3.37%
0.73%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):